carbapenems has been researched along with Communicable Diseases, Emerging in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alavi-Moghaddam, M; Ghalavand, Z; Goudarzi, H; Houri, H; Nikmanesh, B; Salehi, B | 1 |
| Del Valle-Mendoza, J; Levy-Blitchtein, S; Moreno-Morales, J; Muñoz, L; Plasencia-Rebata, S; Pons, MJ; Roca, I; Velásquez-Pomar, J; Vicente-Taboada, W; Vila, J | 1 |
| Lutgring, JD | 1 |
| Albrecht, V; Ansari, U; Beldavs, Z; Bower, C; Bulens, SN; Cassidy, PM; Concannon, C; Culbreath, K; Dumyati, G; Grass, JE; Halpin, AL; Hancock, EB; Hardy, DJ; Jacob, J; Kainer, MA; Kallen, A; Karlsson, M; Mounsey, J; Muleta, D; Oethinger, M; Phillips, WE; Phipps, EC; Rasheed, JK; Stanton, R; Vargas, RL; Walters, MS | 1 |
| Cunliffe, NA; Drew, RJ; Hill, RL; Livermore, DM; Paulus, S; Turton, JF; Woodford, N | 1 |
| Bamberg, WM; Bulens, SN; Chea, N; Concannon, C; Culbreath, K; Dumyati, G; Guh, AY; Janelle, SJ; Kainer, MA; Kallen, AJ; Kongphet-Tran, T; Limbago, B; Lynfield, R; Muleta, DB; Phipps, EC; Shaw, KM; Vaeth, E; Vagnone, PS; Wilson, L | 1 |
| Cornaglia, G; Rossolini, GM | 1 |
| Berhin, C; Bogaerts, P; Denis, O; Deplano, A; Glupczynski, Y; Huang, TD; Jans, B | 1 |
| Diene, SM; Fall, B; Fenollar, F; Kempf, M; Niang, B; Raoult, D; Rolain, JM; Sow, K; Wade, B | 1 |
1 review(s) available for carbapenems and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Communicable Diseases, Emerging; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Phenotype | 2019 |
8 other study(ies) available for carbapenems and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Communicable Diseases, Emerging; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals, Teaching; Humans; Intensive Care Units; Iran; Minocycline; Molecular Typing; Tigecycline | 2018 |
Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Communicable Diseases, Emerging; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Peru | 2018 |
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Communicable Diseases, Emerging; Comorbidity; Female; History, 21st Century; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Public Health Surveillance; United States; Young Adult | 2019 |
Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Communicable Diseases, Emerging; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Minisatellite Repeats; Molecular Typing; Polymerase Chain Reaction; Prevalence; Retrospective Studies; Tertiary Care Centers; United Kingdom | 2013 |
Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Communicable Disease Control; Communicable Diseases, Emerging; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Phenotype; Public Health Surveillance; United States | 2015 |
The emerging threat of acquired carbapenemases in Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Communicable Diseases, Emerging; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans | 2010 |
Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Belgium; beta-Lactamases; Carbapenems; Communicable Diseases, Emerging; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2011 |
Emergence of the OXA-23 carbapenemase-encoding gene in multidrug-resistant Acinetobacter baumannii clinical isolates from the Principal Hospital of Dakar, Senegal.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Senegal; Young Adult | 2013 |